Spudich, Rutter to lead start-up Kainomyx; plus Sanofi licenses Kiadis' NK cell therapy to pair with #multiplemyeloma therapy, deals on Angelman's, HIV in today's @BioCentury roundup $SNY $KDS $OVID $MRK $CYTK https://t.co/SIFmgOq91f